AGP Picks
View all

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on September 9, 2026

Classmates.com Launches New Blog to Celebrate 30 Years of Reconnecting Alumni
Creative Biolabs Expands Integrated AI-Driven Chemical Synthesis Platforms to Accelerate Next-Generation Drug Discovery
SEALSQ Expands its Quantum Highway™: Nine Interconnected Hubs Now Link La Línea, Murcia, Toulouse, Meyreuil, Grenoble, Geneva, Lausanne and the Future Swiss-based Center, and Extend the Sovereign Quantum Corridor to Chicago with EeroQ
Association of Clinical Research Professionals Opens Applications for 2026–27 Scholarships and Grants Program
Human Centered Holdings applies to steward .human
Penta Security to Participate in GISEC Global 2026, the Middle East’s Largest Cybersecurity Exhibition
Intermediate Bulk Container Market (IBC) Competitive Insights, Demand Analysis
PageUp Achieves ISO/IEC 42001:2023 Certification for Artificial Intelligence Management Systems
Flexible Packaging Market Size Demand Competitive Insights
SASE OpsLab Ltd Appoints Cybersecurity Veteran Franck Burtin as Chief Revenue Officer to Drive Global SASE Automation Expansion
Presentations.ai Slide Generator for Investor Pitch Decks and Sales PPT's 2026 Update - 12 Million Users Trust The AI Powerpoint Maker To Automate and Scale Professional AI Slide Generation With Branding, Design and Data
HIZERO Takes an Exciting Leap Forward at IFA 2026, Sparking a Surge of Interest in Its Broadened No Suction Technology™ Range
Trethera Congratulates Board Director Dr. Timothy R. Donahue on Appointment to Senior Leadership Roles at Weill Cornell Medicine and NewYork-Presbyterian
Ladies of Porter Ranch Partners with American Red Cross for Community Blood Drive During Sickle Cell Awareness Month
2026 Kantar BrandZ Top 100 Most Valuable Chinese Brands unveiled: seven new entrants join the ranking as total brand value grows by 13%
OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101) for the Prevention of Organ Rejection in Kidney Transplant Recipients
OSE Immunotherapeutics se félicite de l’inclusion du premier patient traité par Veloxis dans l’étude de phase 2 RENGEVITY-201 évaluant le pegrizeprument (VEL-101) dans la prévention du rejet d’organe  chez les patients transplantés rénaux
Carahsoft and Sonar Expand Partnership to Deliver AI Code Verification and Governance Across All North American Markets
Temperature Controlled Packaging Solutions Market
Eutelsat and OroraTech Partner to Deploy Up to 96 Thermal Infrared Payloads

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Science Press Releases

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.